The 9th International Conference on Biomedical Engineering and Biotechnology (ICBEB 2020) will be held during November 15-18, 2020 in Suzhou, China. ICBEB aims to provide an extensive platform for scientists, researchers and scholars to present their research results and newest findings in all fields of Biomedical Engineering and Biotechnology, discuss the practical challenges encountered and recommend better solutions for human health.
The plenary session will include keynote speeches, invited speeches, oral presentations and poster presentations. The 3rd China Physiological Signal Challenge (CPSC 2020) will be held synchronously during the conference.
Suzhou, alternately romanized as Soochow, is a major city located in southeastern Jiangsu Province of East China, about 100 km (62 mi) northwest of Shanghai. It is a major economic center and focal point of trade and commerce, and the second largest city in the province, after its capital Nanjing. Praised as the 'Venice of the Orient', Suzhou is a desirable travel destination all year round with mild climate and exquisite classical gardens in the downtown area. It is famous for its over 60 Classical Gardens, collectively a World Heritage Site with the Most UNESCO-recognized gardens in the world.
We cordially invite you to join us in Suzhou, China!
Congratulations that 7 winners of the Best Oral Presentations from ICBEB 2019 are awarded with free registration to ICBEB 2020:
Congratulations! 4 winners of the Best Poster Presentations from ICBEB 2019 are awarded with free accommodation to ICBEB 2020.
Congratulations! 3 winners of the Best Papers from ICBEB 2019 are awarded with free registration to ICBEB 2020.
Congratulations that 3 groups of winners who obtained the highest final QRSacc scores and HRacc scores on the hidden test data have received certificates and generous bonuses in CPSC 2019:
ICBEB 2020 proposes a Special Session entitled H2020 BAMOS - Biomaterials and Additive Manufacturing for early intervention of osteoarthritis.
Prof. Chaozong Liu, University College London, The Royal National Orthopaedic Hospital, UK
Prof. Ling Wang, Xi’an Jiaotong University, China
Osteoarthritis (OA) is a degenerative joint disease, typified by a loss of quality of cartilage and changes in bone at the interface of a joint, resulting in pain, stiffness and reduced mobility. H2020 BAMOS project aims to establish and embed a new collaboration between six internationally leading research organizations (four universities, one healthcare provider and one manufacturer with expertise in additive manufacturing) in addressing the challenges in OA treatment by providing novel cost effective osteochondral scaffold technology for early intervention of OA to delay or avoid the joint replacement operations by develop new materials and manufacturing technologies for the fabrication of custom-tailored osteochondral scaffolds. This session is to share the achievement of the BAMOS project within TERMIS community, and interact with colleagues who have the same interest in early OA intervention.
Please visit http://www.icbeb.org/session.html for more details on the Special Session-H2020 BAMOS.
|Basic & Clinical Pharmacology & Toxicology (Abstracts)
ISSN (online): 1742-7843
JCR Impact factor: 2.452
Publication Type: Supplement issue
Indexed in: Science Citation Index (Clarivate Analytics), Science Citation Index Expanded (Clarivate Analytics), MEDLINE/PubMed (NLM), etc.
Journal of Bioinformatics and Computational Biology
ISSN (online): 1757-6334
JCR Impact factor: 0.845
Publication Type: Special issue
Indexed in: Science Citation Index Expanded, Journal Citation Reports/Science Edition, Scopus, Google Scholar, CNKI Scholar, MEDLINE etc.
Technology and Health Care
ISSN (online): 1878-7401
JCR Impact factor: 0.787
Publication Type: Supplement issue
Indexed in: Science Citation Index-Expanded (SciSearch®), MEDLINE, Pubmed Central, Scopus etc.